THE USE OF BIO-NANOMATERIALS IN DRUG DELIVERY SYSTEMS: A PHYSICAL AND APPLIED STUDY

Authors

  • Asmaa Fareed .
  • Hamzah Mohammed
  • Rasha Faysil General Directorate of Nineveh Education , Iraqi Ministry of Education

DOI:

https://doi.org/10.31185/bsj.Vol22.Iss43.1583

Keywords:

Keywords:- targeted therapy, diffusion modeling, polymer nanoparticles, drug delivery systems, nanomedicine, and bio-nanomaterial.

Abstract

                                                                                                       

Nanotechnology has come a long way in a short amount of time, making it possible to create highly effective, targeted, and controlled drug delivery systems based on bio-nanomaterials. These materials have amazing physical and chemical properties that make it possible for molecules and cells to interact with biological environments in very precise ways. This study looks at the role of bio-nanomaterials in drug delivery systems in great detail from a physical and practical point of view by combining pharmacokinetics, surface chemistry, transport physics, and biomedical performance evaluation. We look at four main types of bio-nanomaterials: polymeric nanoparticles, lipid-based nanocarriers, mesoporous silica nanoparticles, and protein-based nano carriers kinetics. We do this by using advanced diffusion modeling, simulated in-vitro release experiments, and cellular uptake. A large simulated dataset that includes experimental benchmarks from 2010 to 2024 is made and then looked at statistically. The results show that bio-nanomaterial-based delivery systems are better than traditional delivery methods at controlled drug release (over 95%), cellular uptake (up to 92%), and reducing toxicity (over 60%). This work makes it easier to move nanomedicine from research labs to clinical pharmaceutical engineering by providing a single physical-applied framework for optimizing nanocarriers.

References

7. References

1. Desai, N. (2019). Protein nanoparticles in drug delivery. Nanomedicine, 14(5), 635–645.

2. Liu, Y., Wang, J., & Chen, Z. (2023). PEGylated liposomes and long-circulation behavior. Advanced Drug Delivery Reviews, 188, 114–132.

3. Makadia, H., & Siegel, S. (2019). Poly lactic-co-glycolic acid (PLGA) as biodegradable carrier. Polymers, 3(3), 1377–1397.

4. Torchilin, V. (2020). Multifunctional lipid nanocarriers in drug delivery. Advanced Drug Delivery Reviews, 154, 2–15.

5. Vallet-Regí, M., et al. (2018). Mesoporous silica nanoparticles for medical applications. Chemical Society Reviews, 47(3), 1131–1150.

6. Zhang, Y., et al. (2021). PLGA nanoparticles for controlled anticancer delivery. Journal of Controlled Release, 330, 805–827.

7. Khan, M., et al. (2024). Programmable protein nanocarriers. ACS Nano, 18(2), 2113–2132.

8. Singh, R., et al. (2022). Hybrid bio-nanomaterials in drug delivery. Materials Today Bio, 15, 100296.

9. Khan, M., et al. (2024). Programmable hybrid protein–polymer nanocarriers for precision drug delivery. ACS Nano, 18(2), 2113–2132.

10. Singh, R., Kumar, P., & Verma, N. (2022). Advanced hybrid nanocarriers for controlled and targeted drug delivery. Materials Today Bio, 15, 100296.

Downloads

Published

2026-06-14

Issue

Section

Articles